Hungary Richter seen reporting drop in Q3 profits

Pharma company to publish earnings report early on Thursday.

Hungary's Richter receives good news

Pharmafarm is back in business.

Hungary's Richter to sell new drug in EU

Signs license and distribution agreement.

Hungary Richter adds new item to product line

Women's Healthcare portfolio expanded.

ANALYST VIEW - New target price for Hungary's Richter: HUF 6,000

J.P. Morgan also cuts rating.

Hungary's Richter receives bad news regarding Esmya

U.S. FDA rejects application by Allergan.

Profit of Hungary's Richter takes off in Q2

Richter pampers shareholders with positive surprises.

Hungary Richter seen reporting profit boom for Q2

There are some crucial questions, though.

Reporting season kicks off in Hungary - Richter is first in line

Mol is also set to release earnings report this week.

Hungary Richter gets news about flagship product Esmya

European Commission takes decision.

Hungary Richter buys intellectual property rights

For drug launch in the United States.

Romanian wholesaler of Hungary's Richter suspended

Hungary's leading pharma company reacts.

Flagship product of Hungary's Richter awaits Commission opinion

Recommendations for Esmya approved by CHMP.

ANALYST VIEW - Jefferies lowers target price for Hungary's Richter

To HUF 5,470 from HUF 5,695.

Risk assessment body makes recommendations on Richter's Esmya

Esmya may remain on markets but with restrictions.

ANALYST VIEW - Hungary's Richter gets 'Hold' rating from Jefferies

After release of Q1 earnings report.

Hungary Richter to reveal Q1 results on Tuesday - What to expect?

Analysts are split over after-tax profit.

Hungary pharma Richter posts record-low profit over Esmya

Good news about flagship product of Hungary's Richter

Share price on the rise.

Hungary Richter to pay HUF 68 dividend per share

Annual General Meeting is coming up.